Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly

Daniel Schöttle; Klaus Wiedemann; Christoph U Correll; Wolfgang Janetzky; Michael Friede; Holger Jahn; Andreas Brieden

doi:10.1016/j.schres.2023.08.026

Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly

Schizophr Res. 2023 Oct:260:183-190. doi: 10.1016/j.schres.2023.08.026. Epub 2023 Sep 6.

Authors

Daniel Schöttle¹, Klaus Wiedemann², Christoph U Correll³, Wolfgang Janetzky⁴, Michael Friede⁵, Holger Jahn⁶, Andreas Brieden⁷

Affiliations

¹ Klinik für Psychiatrie und Psychotherapie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. Electronic address: d.schoettle@uke.de.
² Klinik für Psychiatrie und Psychotherapie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
³ Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany. Electronic address: christoph.correll@charite.de.
⁴ Lundbeck GmbH, Ericusspitze 2, 20457 Hamburg, Germany. Electronic address: woja@lundbeck.com.
⁵ Lundbeck GmbH, Ericusspitze 2, 20457 Hamburg, Germany. Electronic address: lumf@lundbeck.com.
⁶ AMEOS Kliniken Heiligenhafen, AMEOS Krankenhausgesellschaft Holstein mbH, Oldenburg i. H., Preetz, Kiel, Germany. Electronic address: holger.jahn@ameos.de.
⁷ Universität der Bundeswehr München, Werner-Heisenberg-Weg 39, D-85577 Neubiberg, Germany. Electronic address: andreas.brieden@unibw.de.

PMID: 37683508
DOI: 10.1016/j.schres.2023.08.026

No abstract available

Keywords: Aripiprazole; Biostatistics; Constrained confidence partitioning; Long-acting injectable; Prediction; Response; Schizophrenia; Structure detection.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antipsychotic Agents* / adverse effects
Aripiprazole / adverse effects
Delayed-Action Preparations / therapeutic use
Humans
Piperazines / therapeutic use
Schizophrenia* / chemically induced
Schizophrenia* / drug therapy

Substances

Aripiprazole
Antipsychotic Agents
Piperazines
Delayed-Action Preparations